Sponsor
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
Posted
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns with the company's expectation that 50% of its revenue will come from the U.S. by 2030. The decision comes amid rising tariff pressures from the Trump administration, aiming to bolster domestic drug supply chains.
Căutare
Categorii
- National
- International
- Business
- Technology
- Health
- Educaţie
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Citeste mai mult
Today’s News in a Nutshell
KATHMANDU: Khabarhub brings you a glimpse of major developments of the day in Nepal, including...
Hockey: Cash-strapped Pakistan might be forced to skip FIH Pro League despite invitation
Pakistan's potential return to international hockey faces uncertainty as financial constraints...
Prithviraj says Ibrahim deserved debut with Sarzameen, not Nadaaniyan
Prithviraj Sukumaran believes that Sarzameen would have been a more impactful debut for Ibrahim...
Who is Antonio Gracias? Musk ally quits DOGE; faced conflict of interest allegations
Antonio Gracias, a close associate of Elon Musk, has stepped down from his role at a US...